Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - 21 CFR Part 314
          - [Docket No. FDA-2009-N-0316]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Final rule; technical amendment.

# SUMMARY:

The Food and Drug Administration (FDA) is amending its new drug application (NDA) and abbreviated new drug application (ANDA) regulations to correct the address for the Orange Book Staff in the Office of Generic Drugs. This action is being taken to ensure accuracy and clarity in the agency's regulations.

# DATES:

This rule is effective July 24, 2009.

# FOR FURTHER INFORMATION CONTACT:

Olivia A. Pritzlaff, Center for Drug Evaluation and Research, Food and Drug Administration, Bldg. 51, rm. 6308, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-3506.

# SUPPLEMENTARY INFORMATION:

FDA is amending its regulations in part 314 (21 CFR part 314) to correct the address for Orange Book Staff in the Office of Generic Drugs in §§ 314.52(a)(2), 314.53(f), and 314.95(a)(2).

# List of Subjects in 21 CFR Part 314

      - Administrative practice and procedure
      - Confidential business information
      - Drugs
      - Reporting and recordkeeping requirements

                        Therefore, under the Federal Food, Drug, and Cosmetic Act and under                               ( print page 36605)                            authority delegated to the Commissioner of Food and Drugs, 21 CFR part 314 is amended as follows:                    

# PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG

1. The authority citation for 21 CFR part 314 continues to read as follows:

Authority:21 U.S.C. 321, 331, 351, 352, 353, 355, 356, 356a, 356b, 356c, 371, 374, 379e.

§ 314.52

2. Section 314.52 is amended in paragraph (a)(2) by removing “at the address identified on FDA's Web site ( *http://www.fda.gov/​cder/​ogd*)” and by adding in its place “7500 Standish Pl., Rockville, MD 20855”.                    

§ 314.53

3. Section 314.53 is amended in paragraph (f) by removing “at the address identified on FDA's Web site ( *http://www.fda.gov/​cder/​ogd*)” and by adding in its place “7500 Standish Pl., Rockville, MD 20855”.                    

§ 314.95

4. Section 314.95 is amended in paragraph (a)(2) by removing “at the address identified on FDA's Web site ( *http://www.fda.gov/​cder/​ogd*)” and by adding in its place “7500 Standish Pl., Rockville, MD 20855”.                    

Dated: July 17, 2009.

Jeffrey Shuren,

Associate Commissioner for Policy and Planning.

[FR Doc. E9-17680 Filed 7-23-09; 8:45 am]

BILLING CODE 4160-01-S